Naxiflox MZ Oral Suspension is a combined antibacterial medication containing Ofloxacin (50mg) and Metronidazole (100mg) per 5mL. Indicated for the treatment of various bacterial infections, including skin and skin structure infections, genitourinary tract infections, intra-abdominal infections, and respiratory tract infections caused by susceptible organisms. Ofloxacin, a fluoroquinolone, exhibits a broad spectrum of antibacterial activity, while Metronidazole is effective against anaerobic and microaerophilic bacteria. The dosage and duration of therapy should be determined by the prescriber, based on the specific infection and patient's condition. It is essential to complete the full course of therapy to ensure effective treatment and minimize the risk of treatment failure or recurrence.